The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease

被引:94
|
作者
Song, Myeong Jun [1 ,2 ]
Malhi, Harmeet [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea
关键词
Nonalcoholic steatohepatitis; Lipotoxicity; Endoplasmic reticulum stress; Palmitate; Sphingolipids; ENDOPLASMIC-RETICULUM-STRESS; QUALITY-CONTROL PROTEINS; GROWTH-FACTOR; 21; ER-STRESS; TRANSCRIPTION FACTOR; URSODEOXYCHOLIC ACID; NONALCOHOLIC STEATOHEPATITIS; TAUROURSODEOXYCHOLIC ACID; MESSENGER-RNAS; TRANSMEMBRANE PROTEIN;
D O I
10.1016/j.pharmthera.2019.107401
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nonalcoholic fatty liver disease is a major public health burden. Although many features of nonalcoholic fatty liver disease pathogenesis are known, the specific mechanisms and susceptibilities that determine an individual's risk of developing nonalcoholic steatohepatitis versus isolated steatosis are not well delineated. The predominant and defining histologic and imaging characteristic of nonalcoholic fatty liver disease is the accumulation of lipids. Dysregulation of lipid homeostasis in hepatocytes leads to transient generation or accumulation of toxic lipids that result in endoplasmic reticulum (ER) stress with inflammation, hepatocellular damage, and apoptosis. ER stress activates the unfolded protein response(UPR)which is classically viewed as an adaptive pathway to maintain protein folding homeostasis. Recent studies have uncovered the contribution of the UPR sensors in the regulation of hepatic steatosis and in the cellular response to lipotoxic stress. Interestingly, theUPR sensors can be directly activated by toxic lipids, independently of the accumulation of misfolded proteins, termed lipotoxic and proteotoxic stress, respectively. The dual function of the UPR sensors in protein and lipid homeostasis suggests that these two types of stress are interconnected likely due to the central role of the ER in protein folding and trafficking and lipid biosynthesis and trafficking, such that perturbations in either impact the function of the ER and activate the UPR sensors in an effort to restore homeostasis. The precise molecular similarities and differences between proteotoxic and lipotoxic ER stress are beginning to be understood. Herein, we provide an overview of the mechanisms involved in the activation and cross-talk between the UPR sensors, hepatic lipid metabolism, and lipotoxic stress, and discuss the possible therapeutic potential of targeting the UPR in nonalcoholic fatty liver disease. (C) 2019 Published by Elsevier Inc.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
    Mato, Jose M.
    Alonso, Cristina
    Noureddin, Mazen
    Lu, Shelly C.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (24) : 3009 - 3020
  • [22] Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
    Dashti, Zahra
    Yousefi, Zeynab
    Kiani, Pouria
    Taghizadeh, Motahareh
    Maleki, Mohammad Hasan
    Borji, Mohammad
    Vakili, Omid
    Shafiee, Sayed Mohammad
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 154
  • [23] Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver
    Ramos, Leticia F.
    Silva, Caio M.
    Pansa, Camila C.
    Moraes, Karen C. M.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (01) : 25 - 40
  • [24] Effects of triglyceride and ethyl ester forms of EPA on hepatic lipid metabolism in mice with non-alcoholic fatty liver disease
    Feng, Junli
    Wang, Shitong
    Chen, Feifei
    Zhang, Jian
    Wang, Qingcheng
    Jiang, Lili
    Wang, Zejun
    Shen, Qing
    JOURNAL OF FUNCTIONAL FOODS, 2024, 116
  • [25] Effect of Liver X receptor in liver lipid metabolism in patients with non-alcoholic fatty liver disease
    Ahn, Sang Bong
    Son, Byoung Kwan
    Jun, Dae Won
    HEPATOLOGY, 2013, 58 : 542A - 542A
  • [26] SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease
    Liu, Yuhan
    Yu, Fudong
    Han, Yan
    Li, Qing
    Cao, Zhujun
    Xiang, Xiaogang
    Jiang, Shaowen
    Wang, Xiaolin
    Lu, Jie
    Lai, Rongtao
    Wang, Hui
    Cai, Wei
    Bao, Shisan
    Xie, Qing
    SCIENTIFIC REPORTS, 2016, 6
  • [27] Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease
    Jegatheesan, Prasanthi
    Beutheu, Stephanie
    Ventura, Gabrielle
    Sarfati, Gilles
    Nubret, Esther
    Kapel, Nathalie
    Waligora-Dupriet, Anne Judith
    Bergheim, Ina
    Cynober, Luc
    De-Bandt, Jean-Pascal
    CLINICAL NUTRITION, 2016, 35 (01) : 175 - 182
  • [28] Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease
    Zhang, He
    Yang, Liying
    Wang, Yichao
    Huang, Wenli
    Li, Yang
    Chen, Shuchun
    Song, Guangyao
    Ren, Luping
    LIFE SCIENCES, 2020, 257
  • [29] SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease
    Yuhan Liu
    Fudong Yu
    Yan Han
    Qing Li
    Zhujun Cao
    Xiaogang Xiang
    Shaowen Jiang
    Xiaolin Wang
    Jie Lu
    Rongtao Lai
    Hui Wang
    Wei Cai
    Shisan Bao
    Qing Xie
    Scientific Reports, 6
  • [30] Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota
    Han, Ruiting
    Qiu, Huihui
    Zhong, Jing
    Zheng, Ningning
    Li, Bingbing
    Hong, Ying
    Ma, Junli
    Wu, Gaosong
    Chen, Linlin
    Sheng, Lili
    Li, Houkai
    PHYTOMEDICINE, 2021, 85